Watertown, MA, United States of America

Kevin Kesper

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Kevin Kesper: Innovator in Pharmaceutical Compositions

Introduction

Kevin Kesper, based in Watertown, MA, is a notable inventor with a focus on pharmaceutical innovations. With an impressive portfolio consisting of three patents, he has made significant contributions to the field of drug formulation, particularly revolving around the stabilization of essential pharmaceutical compounds.

Latest Patents

Kesper's latest patents showcase his expertise in developing irinotecan phospholipid liposomes that enhance storage stability. These innovative pharmaceutical compositions aim to reduce the formation of lyso-phosphatidylcholine (lyso-PC), which is crucial for improving the efficacy of drug delivery. Both patents highlight methods of treatment and manufacture that align with his goal of optimizing patient care through more reliable pharmaceutical products.

Career Highlights

As an inventor at Ipsen Biopharm Limited, Kevin has contributed his knowledge and skills to advance the company's mission in developing groundbreaking therapeutics. His work emphasizes a commitment to improving the stability and efficacy of essential cancer treatments.

Collaborations

Throughout his career, Kesper has collaborated with esteemed colleagues, including Daryl C Drummond and Dmitri B Kirpotin. These partnerships reflect a synergy of expertise in the realm of pharmaceutical innovation, allowing for the consolidation of ideas and advancements in research.

Conclusion

In summary, Kevin Kesper stands as a significant figure in the field of pharmaceutical inventions. His work in stabilizing pharmaceutical compositions not only benefits the research institution he is associated with but also contributes to the broader field of medicine through improved patient care options. With a continued focus on innovation, Kesper is poised to push the boundaries of pharmaceutical formulations even further.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…